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Passage of Ross River virus strain NB5092 in avian cells has been previously shown to select for virus
variants that have enhanced replication in these cells. Sequencing of these variants identified two independent
sites that might be responsible for the phenotype. We now demonstrate, using a molecular cDNA clone of the
wild-type T48 strain, that an amino acid substitution at residue 218 in the E2 glycoprotein can account for the
phenotype. Substitutions that replaced the wild-type asparagine with basic residues had enhanced replication
in avian cells while acidic or neutral residues had little or no observable effect. Ross River virus mutants that
had increased replication in avian cells also grew better in BHK cells than the wild-type virus, whereas the
remaining mutants were unaffected in growth. Replication in both BHK and avian cells of Ross River virus
mutants N218K and N218R was inhibited by the presence of heparin or by the pretreatment of the cells with
heparinase. Binding of the mutants, but not of the wild type, to a heparin-Sepharose column produced binding
comparable to that of Sindbis virus, which has previously been shown to bind heparin. Replication of these
mutants was also adversely affected when they were grown in a CHO cell line that was deficient in heparan
sulfate production. These results demonstrate that amino acid 218 of the E2 glycoprotein can be modified to
create an heparan sulfate binding site and this modification expands the host range of Ross River virus in
cultured cells to cells of avian origin.
Alphaviruses are blood-borne pathogens transmitted by ar-
thropod vectors. The major vertebrate reservoir for many of
these viruses is birds, but many alphaviruses utilize small mam-
mals and some use only mammals as vertebrate hosts. The host
range of these viruses is extremely broad, and they infect many
types of animals and most cells in culture (27). Even within an
infected animal, the virus replicates in many tissues of the host
(10). This extended host and tissue specificity is governed pri-
marily by the ability of the viruses to attach to and enter target
cells. It has been suggested that alphaviruses utilize multiple
receptors to gain access to a wide variety of hosts or, alterna-
tively, that ubiquitous proteins among diverse species serve as
cellular receptors for these viruses (26).
Ross River virus (RRV) is the causative agent of human
epidemic polyarthritis in Australia (7). The prototype T48
strain of RRV, originally isolated in northern Queensland,
Australia, is responsible for yearly outbreaks of disease in
Australia, and its recent spread to Fiji, American Samoa, and
the Cook Islands has had significant consequences for its hu-
man hosts (1, 19). Unlike many of its alphavirus relatives, there
is no evidence for the association of the virus with birds, and it
appears to utilize small mammals, particularly marsupials, as a
reservoir (19). In cell culture, RRV replicates poorly in cells of
avian origin, and thus there may be a restriction to the growth
of the virus in birds (13).
The replication efficiencies of two genetically distinct strains
of RRV, the prototype strain T48 and an attenuated mouse
strain, NB5092, were examined in chicken cells in a study by
Kerr et al. (13). Neither virus grew in chicken embryo fibro-
blasts (CEF) at 37°C, but both could be propagated at 30°C.
NB5092 reached titers that were 100-fold higher than that of
the T48 strain. Repeated passage of NB5092 in chicken cells
resulted in decreasing virus titers until the fifth passage, at
which point the titer increased. Three independently derived
adapted variants were selected for further analysis. Sequencing
of the subgenomic RNA, which contains the coding region for
the alphavirus structural proteins, revealed that all three vari-
ants had a single amino acid change in the E2 glycoprotein.
Two variants had a lysine for asparagine at position 218, and
the third variant had a lysine for glutamate at position 4. When
virulence was examined in 1-day-old mice, the N218K viruses
were found to be attenuated and to produce less virus, whereas
the E4K virus showed little alteration in replication efficiency.
In addition, the N218K viruses were resistant to neutralization
by monoclonal antibody T10C9, whereas the E4K virus was
resistant to neutralization by monoclonal antibody NB3C4.
Taken together, these results suggested that these residues
may be involved in receptor binding or entry of RRV into the
cell. However, the possibility that changes in the nonstructural
proteins contributed to, or were responsible for, the phenotype
could not be ruled out.
Structural studies using cryoelectron microscopy and image
reconstruction techniques to map features of the virus spike
place E2 residues 4 and 218 close to surface-exposed regions of
the virus. In a study by Paredes et al. (23), a Sindbis virus
(SINV) mutant that was unable to cleave the E2 precursor,
PE2, was examined. Since these mutant virus particles retained
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the E3 peptide, which is N-terminal to E2 in the PE2 precur-
sor, a difference map comparing the wild type and the mutant
viruses revealed the position of E3. This placed the E3 peptide
and, by inference, the N terminus of E2 in a distal portion of
the glycoprotein spike. In a separate study, Smith and col-
leagues (25) also used cryoelectron microscopy to map the
binding site of a neutralizing monoclonal antibody on the sur-
face of RRV. The antibody used was T10C9, which bound in
the vicinity of E2 residue 216, based on sequencing of an
escape variant (29). This antibody bound to an outer portion of
the trimeric spike that did not overlap the E3 site and sug-
gested that residue 218 was also on the exposed exterior sur-
face of the spike.
We have used a full-length cDNA clone of RRV RNA to
generate a panel of mutants with substitutions at residue 218 of
glycoprotein E2. Mutants with basic amino acid substitutions at
position 218 replicated better in chicken cells than wild-type
RRV or mutants with other changes at position 218. Two
mutants, N218R and N218K, infected 40 and 15% of cultured
chicken cells, respectively, whereas the parental RRV infected
less than 2%. Further characterization showed that mutants
that had arginine or lysine at position 218 interacted with the
glycosaminoglycan (GAG) heparan sulfate (HS). This demon-
strates that changes in this region of the E2 glycoprotein ex-
pand the host range of RRV in cell culture by allowing virus to
interact with cell surface HS moieties.
MATERIALS AND METHODS
Viruses and cells. Baby hamster kidney (BHK) and Vero cells were main-
tained in minimum essential media (MEM; Life Technologies, Rockville, Md.)
supplemented with 7.5% fetal bovine serum (FBS; Life Technologies), 13 PSN
(0.05 mg of penicillin per ml, 0.05 mg of streptomycin per ml, and 0.1 mg of
neomycin per ml), 2 mM L-glutamine, and 0.1 mM nonessential amino acids
(Life Technologies). CEF were prepared from 10-day-old White Leghorn em-
bryos, and secondary CEF were used in all experiments. The Chinese hamster
ovary (CHO-K1) cells (ATCC CCL-61) and the derivative cell line CHO18.4m
were generously provided by Andrew Byrnes and Diane Griffin (12). Both CHO
cell lines were maintained in Ham’s F-12 medium supplemented with 10% FBS
and 13 PSN (Life Technologies).
A laboratory-adapted strain of SINV, Toto 1101, and the wild-type T48 strain
of RRV, RR64, were generated from in vitro-transcribed RNA as previously
described (17, 24). Mutant viruses, derived from pRR64, were isolated in an
identical manner and were plaque purified twice in BHK cells. The resulting
virus stocks were sequenced to confirm the inserted mutation and were used in
all subsequent experiments.
Site-directed mutagenesis. Single amino acid substitutions at residue 218 of
the RRV E2 glycoprotein were generated by two methods. Substitutions of the
wild-type asparagine to threonine, lysine, and arginine were carried out by M13
site-directed mutagenesis as described by Kunkel (18). For all other substitutions
at residue 218, a degenerate oligonucleotide was used for DNA amplification by
using PCR. The 59 degenerate primer annealed to nucleotides (nt) 9194 to 9229
[59CACTACCAGTACTGACAAGACCATC(G/C/T)N(G/T)ACATGCAA39]
of the pRR64 cDNA clone. The 39 oligonucleotide primer annealed to nt 9640
to 9665 (59CGGGATC CGGGTTATAGTCCATAATA39) of the pRR64 cDNA
clone. Amplification with Taq DNA polymerase (Promega, Madison, Wis.) pro-
duced a 471-bp product that was subsequently digested with the restriction
endonucleases ScaI and CspI. The resulting 367-bp fragment was inserted into a
similarly digested pRR64 plasmid. Full-length clones were screened by DNA
sequencing using the Thermo Sequenase Cycle Sequencing kit (Amersham Phar-
macia Biotech, Piscataway, N.J.). Clones containing substitutions were se-
quenced across the entire amplified region from the ScaI (nt 9201) to the CspI
(nt 9568) restriction sites.
Growth analysis. For one-step growth analyses, 24-well plates containing ap-
proximately 105 cells per well were used. Virus, at a multiplicity of infection
(MOI) of 5, was adsorbed to cells for 1 h at room temperature. The cells were
then overlaid with media and placed at 37°C. Cells were washed twice with fresh
media every 0.5 h for the first 2 h of infection, after which media were harvested
every 1 h. For cumulative growth analysis, 100-ml aliquots of media were har-
vested at various times posttransfection. Virus titers were determined by plaque
assay in BHK cells.
Virus inhibition assays. To examine the inhibitory effects of polyanions on the
size of plaques formed, between 100 to 200 PFU of virus was adsorbed to cells
for 1 h at room temperature. The inoculum was removed, and the cells were
rinsed twice with phosphate-buffered saline (PBS) containing 1% FBS and were
overlaid with either 1.0% agarose (Life Technologies), 0.8% Bacto agar (Difco
Laboratories, Detroit, Mich.), or 0.8% Bacto agar 1 150 mg of DEAE-dextran
(Sigma, St. Louis, Mo.) in 13 MEM containing 1% FBS.
To examine the effects of heparin on plaque formation, 100 to 200 PFU of
virus was incubated with heparin (sodium salt derived from porcine intestinal
mucosa, catalogue no. H9399; Sigma) in a final volume of 250 ml for 30 min at
4°C. Control viruses were incubated with 0.5 mg of bovine serum albumin
(BSA)/ml in place of heparin. Viruses were adsorbed to cells for 1 h at 4°C, at
which time the inoculum was removed and the cells were washed twice with PBS
containing 1% FBS, followed by the addition of an agarose overlay. Treatment
with heparinase I (Sigma) was performed essentially as previously described (4).
Briefly, cells were treated with heparinase I at 37°C for 1 h, followed by adsorp-
tion of 100 to 200 PFU of virus to cells for 1 h at 4°C, and then treated as
described above.
Virus purification. To prepare high-titer virus stocks, BHK cells were infected
with virus at an MOI of 0.1 PFU/cell for 1 h at 37°C. Cells were overlaid with
MEM supplemented with 1% FBS, PSN, 2 mM L-glutamine, and 0.1 mM non-
essential amino acids. Virus was harvested 16 to 18 h postinfection, when cells
were infected with SINV, or 20 h postinfection, when cells were infected with
RRV or the RRV mutants. Supernatants were clarified, followed by polyethylene
glycol precipitation (final concentration, 10% polyethylene glycol 8000 and 1 M
NaCl) for 6 h at 4°C. Precipitated virus was collected by centrifugation at 1,800 3
g for 10 min at 4°C. The pellet was resuspended in 2 ml of TNE buffer (0.05 M
Tris-HCl [pH 7.2], 0.15 M NaCl, and 0.001 M EDTA) and layered on top of a
linear 20 to 60% (wt/vol) sucrose gradient. The gradient was centrifuged for 2 h
at 160,000 3 g at 4°C. The virus band was collected with a syringe and concen-
trated by centrifugation through a 30% sucrose cushion for 1.5 h at 190,000 3 g.
Virus was resuspended in TNE buffer and assayed for infectivity by plaque assay
and for concentration by measurement of absorbance at 280 nm. The titer was
1.0 3 1010 PFU/ml (approximately 2 mg/ml) for SINV and 3.3 3 109 PFU/ml for
RRV.
Binding to heparin. These experiments were performed essentially as de-
scribed by Byrnes and Griffin (4). A 1-ml heparin-Sepharose column (Amersham
Pharmacia Biotech) was equilibrated with buffer A (0.1 M NaCl, 5 mM phos-
phate [pH 7.5]). Virus (109 PFU; approximately 200 ng) was applied to the
column, followed by washing with 10 ml of buffer A. Virus was eluted with a 50%
linear gradient of buffer B (1 M NaCl, 5 mM phosphate [pH 7.5]) at a rate of 1
ml/min, followed by washing with 100% buffer B for 10 min. Absorbance at 280
nm and conductivity were measured, and 500-ml fractions were collected. Virus
titers were determined by plaque assay of peak fractions on BHK cells, and
Western blot analysis was carried out using a polyclonal anti-E2 for RRV and a
polyclonal anti-E1 for SINV.
RESULTS
RRV is restricted in entry into chicken cells. Most cells in
culture are susceptible to infection by RRV, but in avian cells,
replication is severely reduced (13, 26). Attempts to infect
100% of primary or secondary CEF with RRV by using MOIs
of up to 50 failed to produce infection in greater than 5% of
the cells, as determined by immunofluorescence microscopy
(data not shown). This restriction could be due to a defect in
entry or to a postentry event such as RNA synthesis. To dis-
criminate between these two possibilities, we circumvented the
attachment and entry steps by transfecting RRV RNA tran-
scribed in vitro from the cDNA clone pRR64 into secondary
CEF and compared the amount of virus released against that
from a permissive cell line, BHK (Fig. 1). During the initial
round of replication, in which approximately 1% of the cells
were transfected with RNA, the amounts of RRV released
from CEF and BHK cells were comparable (#24 h posttrans-
6304 HEIL ET AL. J. VIROL.
fection) (Fig. 1). This similarity in replication kinetics sug-
gested that postentry processes occurred at roughly equivalent
rates. However, as secondary infections occurred, the amount
of virus released from infected BHK cells continued to in-
crease, whereas the amount of virus released from CEF re-
mained constant. This suggested the restriction in CEF was
due to a block in the entry of RRV. In contrast, the Toto 1101
SINV replicated to equivalent levels in both CEF and BHK
cells over the course of the experiment (the production of
RRV was delayed relative to SINV in these cells) (Fig. 1).
Mutants at E2–218 have altered replication kinetics. Kerr et
al. (13) found that serial passage of the NB5092 strain of RRV
in chicken cells selected for variants that had changes in E2,
one of which was N218K. Furthermore, a strain of RRV that
caused an epidemic of polyarthritis in the South Pacific some
years ago in which humans were the primary, or only, verte-
brate hosts had the change E2-T219A (3). Thus, it is possible
that residue 218 (and 219) might be involved in interaction of
the virus with the surface of susceptible cells. To examine
whether E2–218 was responsible for the increased growth in
chicken cells, we generated a panel of RRV mutants that had
amino acid substitutions at this residue (Table 1).
Wild-type RRV and the N218 mutants were assayed for
growth in BHK cells by one-step growth analyses (Fig. 2A and
data not shown). BHK cells infected with N218K and N218R
released 5- and 10-fold more virus at 12 h postinfection, re-
spectively, than the wild type. All other RRV mutants had
growth kinetics similar to that of the parental virus (Fig. 2A
and data not shown). This group of N218 mutants (N218Y,
N218E, N218G, N218Q, N218T, and N218V) behaved simi-
larly to the wild-type virus in this and the following assays, and
for the sake of clarity, only the N218Y data are shown.
Similar one-step growth analyses were carried out with sec-
ondary CEF (Fig. 2B and data not shown). The N218K and
N218R mutants produced approximately 32- and 320-fold
more virus, respectively, than did wild-type RRV at 12 h
postinfection. Again, the wild-type virus and the other mutants
tested had similar rates of virus released (Fig. 2B and data not
shown). While N218R and N218K produced more virus than
wild-type RRV in CEF, they were still unable to infect 100% of
the cells. N218R and N218K infected approximately 40% and
10 to 20% of CEF, respectively, as determined by immunofluo-
rescence microscopy and were unable to form plaques on CEF
monolayers (data not shown). In contrast, wild-type RRV in-
fected less than 2% of CEF under similar infection conditions
(26). Consistent with these observations, the adapted mutants
as well as the RRV parent produced much less virus than did
SINV, included as a control, which infects 100% of CEF.
The effect of polyanions upon plaque size. Unpassaged iso-
lates of SINV bind poorly to cultured cells and replicate to low
levels in comparison to cell culture-adapted strains of the virus
(4, 15). It was shown that passaged strains of SINV had ac-
quired the ability to attach to cell surface HS moieties, whereas
the unpassaged strain could not. Analysis of the T48 strain of
RRV indicated that it did not attach to HS moieties or several
other GAGs that were tested (4). However, it was possible that
the enhanced replication observed in the RRV N218R and
N218K mutants is the result of interaction with a GAG such as
HS.
It had been previously shown that polyanions present in agar
affect the plaque size of the SINV Toto 1101 strain (4, 5). Pre-
sumably, the positively charged polyanions inhibit the growth
of virus in agar by acting as a competitor in the interaction of
the virus with the cell surface. This results in a slower-growing
plaque in agar than in agarose, which has a higher purity and
lower GAG concentrations. This assay has previously been
used as a preliminary screen to determine possible viral inter-
actions with GAGs (5). Wild-type RRV, isolated from the
pRR64 full-length cDNA, was examined by this assay, and the
plaque size was not affected by the composition of the overlay
medium, in agreement with previous observations (Fig. 3).
However, the E2 mutants N218R and N218K formed smaller
plaques in the presence of agar than in the presence of agarose
(Fig. 3). The inhibitory effect seen with the agar overlay could
be reversed by the addition of positively charged DEAE-dex-
tran into the overlay medium. Mutants containing substitutions
other than arginine or lysine at E2 residue 218 were not af-
fected by the type of overlay present (Fig. 3 and data not
shown). These results suggested that the N218R and N218K
mutants interact with cell surface GAGs.
Heparin interferes with the binding of RRV mutants to
cultured cells. To examine the possibility that the N218R and
N218K viruses interacted with GAGs, we tested the ability of
TABLE 1. RRV and RRV mutants with substitutions
at amino acid 218 of E2
Virus Codon Plaque size (mm)a
RRV ACC 2.0
N218R AGG 3.5
N218K ACA 3.0
N218Y UAU 2.0
N218E GAG 2.0
N218G GGG 2.0
N218Q CAG 2.0
N218T ACC 2.0
N218V GUG 2.0
a As determined in BHK cells at 48 h postinfection with an agarose overlay.
FIG. 1. Differential growth analysis of RRV and SINV following
transfection with RNA. CEF or BHK cells were transfected with 100
ng of either RRV (pRR64) or SINV (pToto1101) RNA that had been
transcribed in vitro. At various times posttransfection, 100 ml of su-
pernatant was harvested and virus titers were determined by plaque
assay in BHK cell monolayers.
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heparin, a highly sulfated form of HS, to interfere with the
binding of RRV and the RRV mutants to cultured cells. The
first approach used plaque assays in BHK cells in the presence
or absence of heparin. A virus-heparin mixture was inoculated
onto the BHK monolayers to test whether heparin competed
with the putative cell surface HS for interaction with virus. In
these experiments, as well as in the previous experiments car-
ried out with SINV, a vast molar excess of heparin (5.2 3 108
to 2.6 3 1010 molecules of heparin/E2 molecule) was used (4,
15). As shown in Fig. 4A, the presence of heparin inhibited
plaque formation by N218R, N218K, and SINV in a dose-
dependent manner but had little effect on wild-type RRV or
other E2–218 mutants.
Heparin and other free GAGs are known to interact with
cell surface proteins such as fibroblast growth factor receptor
and could possibly interfere with virus attachment by interact-
ing with the cellular receptor (21, 22, 32). However, it seems
unlikely that heparin nonspecifically blocked the attachment of
virus to the cell surface or inhibited virus replication, as the
inhibitory effect appeared to be specific for the E2–218 mu-
tants that had basic amino acid substitutions. The amount of
virus released from heparin-incubated BHK cells that were
infected with wild-type RRV or the other E2–218 mutants was
similar to the amount of virus released from the BSA-incu-
bated BHK control (Fig. 4A).
A similar experiment, examining the ability of heparin to
inhibit virus replication, was performed with CEF cells (Fig.
4B). A virus-heparin mixture was inoculated onto CEF mono-
layers for 1 h at 4°C. Since RRV is unable to form plaques in
CEF, the inhibitory effect of heparin was measured by assaying
the release of virus into a liquid overlay following a 12-h in-
fection. As with BHK cells, incubation with heparin reduced
the yield of SINV, N218R, and N218K but had little or no
effect on the yield of wild-type RRV or the other RRV E2–218
mutants. The reduction in virus released for N218R and
N218K suggests an interaction between these viruses and hep-
arin, as has been previously established for SINV.
Binding of RRV E2–218 mutants to heparin. To examine the
relative affinities of the RRV E2–218 mutants for heparin, 200
ng of virus was bound to heparin-immobilized Sepharose beads
(4, 15). Once bound, virus was eluted with a linear NaCl gra-
dient. Fractions were assayed for the presence of virus by
plaque titration in BHK cells and by Western blot analysis
using a polyclonal anti-E2 antibody for RRV or a polyclonal
anti-E1 antibody for SINV. The N218R and N218K RRV
mutants eluted at 343 and 388 mM NaCl, respectively, com-
pared to 305 mM for SINV (Table 2). Thus, the N218R and
FIG. 2. One-step growth analyses in BHK cells and CEF. BHK cells or CEF were infected with the indicated virus at an MOI of 5. Media were
replaced every 30 min for the first 2 h and then every hour until 12 h postinfection. Supernatants were collected at the indicated times, and released
virus was assayed by titration in BHK cell monolayers at 37°C. The results represent data obtained from two independent experiments. For ease
of viewing, results from only a selected set of mutants are shown. The results with N218Y are representative of the data obtained with N218E,
N218G, N218Q, N218T, and N218V.
FIG. 3. The effect of polyanions on virus plaque size. BHK cells
were infected with virus (100 to 200 PFU) for 1 h at room temperature.
The inoculum was removed, and cells were rinsed twice with PBS
containing 1% FBS. Cells were overlaid with MEM supplemented with
1% FBS and agarose (solid bars), agar (gray bars), or agar containing
150 mg of DEAE-dextran/ml (striped bars). Infection was allowed to
proceed for 48 h, at which time the cells were stained with 5% neutral
red in PBS for 6 h. At 55 h postinfection, the stain was removed and
the size of the plaques was determined. The data are the averages of
20 independent plaque measurements, and error analysis was carried
out using the Student t test.
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N218K mutants have an affinity for heparin similar to that of
SINV. This contrasts with the wild-type RRV, which eluted at
134 mM NaCl. Interestingly, the profile of the wild-type RRV
produced a single elution peak, unlike the two peaks of virus
seen by Byrnes and Griffin (4). In our experiments, we used
virus derived from a full-length cDNA clone of RRV RNA,
pRR64, whereas Byrnes and Griffin used an uncloned stock of
the T48 strain (17). They concluded that their preparation of
virus contained two genetically distinct populations that dif-
fered in their affinity for heparin, eluting from the column at
118 and 189 mM NaCl, respectively. Our preparation of RRV
eluted at an intermediate concentration. It is clear that the
RRV mutants E2-N218R and E2-N218K have a much higher
affinity for heparin than does the parental RRV or any of the
other E2–218 mutants.
Attachment to cell surface GAGs. A CHO cell line,
CHO18.4m, that has a reduced susceptibility to infection by
SINV was generated by the retrovirus-directed insertion of the
neomycin resistance gene into a transcriptionally active gene
(12). This cell line has been shown to be deficient in binding
laboratory-adapted strains of SINV due to the loss of expres-
sion of HS at the cell surface. These cells were used to examine
the replication of N218R and N218K as well as wild-type RRV
and the Toto1101 SINV. Plaque assays carried out in parallel
with the parental CHO cells and the CHO18.4m cells demon-
strated that the plaque size was smaller in the CHO18.4m cells
than in the parental cells in the case of N218R, N218K, and
SINV (Table 2). Furthermore, the yield of virus from infected
CHO18.4m cells was also less than that from the parental cells
for these viruses (Table 2). In contrast, the wild-type RRV
showed little difference in either plaque size or virus release in
the two cell lines. The N218Y virus was also relatively insen-
sitive to the cell line. These data strongly suggest that the
N218K and N218R mutants utilize HS for entry.
Heparinase I reduces plaque formation of RRV E2-218 mu-
tants in BHK cells. Heparinase I degrades the a1–4 glycosidic
bond of HS. BHK cells were pretreated with various amounts
of heparinase I and used in plaque assays with a constant
amount of virus (Fig. 5 and data not shown). The number of
N218R, N218K, and SINV plaques formed in cells treated with
heparinase I was reduced, whereas plaques produced by RRV
and the other RRV 218 mutants were not affected by such
treatment of cells. This inhibition is unlikely to be the result of
nonspecific proteolysis because it is specific for the N218R and
N218K mutants and because incubation of CHO18.4m with
heparinase I did not reduce the number of plaques formed on
these cells (4). These data demonstrate that the N218K and
N218R mutants utilize the cell surface GAG, HS, for entry into
cells.
DISCUSSION
The region around amino acid 216 of RRV has been previ-
ously implicated as a site of interaction with the host. Molec-
ular genetic studies described here demonstrate that a single
amino acid change in this region of the protein adapts the virus
to cell surface HS moieties. This adaptation for HS attachment
appears to require a positively charged amino acid, as arginine
and lysine confer binding, whereas acidic or neutral residues
have little or no effect. Mutations at the neighboring E2 thre-
onine-216 have a similar affect on HS binding, suggesting that
HS binding occurs in this region of the glycoprotein (data not
TABLE 2. Properties of RRV and RRV E2-218 mutants
Virus
Heparin-
Sepharose
elution
(mM NaCl)a
Plaque diam (mm)b Titer log (PFU/ml)b
CHO CHO18.4m CHO CHO18.4m
RRV 134 1.8 6 0.1 1.5 6 0.1 7.7 6 0.3 7.6 6 0.1
N218R 343 2.0 6 0.1 0.3 6 0.1 7.6 6 0.3 6.5 6 0.5
N218K 388 2.0 6 0.1 0.3 6 0.1 7.8 6 0.3 5.5 6 0.2
N218Y ND 1.8 6 0.1 1.5 6 0.2 7.8 6 0.1 6.3 6 0.1
SINV 305 3.0 6 0.2 0.3 6 0.2 8.3 6 0.1 6.9 6 0.2
a Salt concentration of peak virus elution. ND, not determined.
b Measured 55 h postinfection. The experiment was performed twice in dupli-
cate.
FIG. 4. The effect of heparin on infection by viruses. Various concentrations of heparin were added to solutions of viruses and incubated for
30 min at 4°C. Media were removed from monolayers of cells and replaced with the virus-heparin inoculum. Following adsorption of virus for 1 h
at 4°C, the inoculum was removed and an agarose overlay (BHK cells) or MEM supplemented with 2% FBS (CEF) was added. In the case of BHK
cells, plaques were counted at 50 h postinfection. For CEF, the infection was allowed to proceed for 18 h, at which time the supernatants were
collected and virus was assayed by plaque titration of BHK cells. Results are presented as a percentage of the control, where the control is the same
virus in the absence of heparin but containing 0.5 mg of BSA/ml.
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shown). In addition, cryoelectron microscopy and image recon-
struction studies of the E2 N218R virus complexed with hep-
arin have shown that the binding site for heparin overlaps a
significant portion of the footprint of monoclonal antibody
T10C9 (W. Zhang, M. L. Heil, T. S. Baker, and R. J. Kuhn,
unpublished data).
Although substitution of a basic amino acid at either the 216
or 218 residue confers HS binding, the data do not establish
whether this binding site is conformational or linear. Studies of
HS binding have defined the sequences XBXBBBX or XB-
BXBX (where X is any residue and B is a basic residue) as
linear HS-binding motifs that allow proteins to attach to HS.
This motif is not present in the E2–216 to -218 region even
after the basic amino acid substitutions. An HS-binding motif
is present in E2 at residue 249 but does not appear to confer
HS binding in the wild-type virus. In studies of SINV, one
region that binds HS has been found to overlap a predicted HS
interaction domain (E2 arginine-1), but other binding sites do
not, suggesting that they may be conformational (14, 15). This
is not a unique observation, as foot-and-mouth disease virus
type O is known to interact with HS in a conformation-depen-
dent manner. Structural studies revealed that heparin bound
near the south wall of the picornavirus canyon, in contact with
the three capsid proteins VP1, VP2, and VP3. The most critical
contact, as shown by the crystal structure of the complex, is an
ionic interaction between arginine-56 of VP3 and the 2-N-
sulfate of GlcN-2 from heparin (8).
Numerous viruses have been shown to utilize HS for infec-
tion of cells, including the alphaherpesviruses (31), the beta-
herpesviruses (20), foot-and-mouth disease virus type O strains
(8), papillomavirus (9), respiratory syncytial virus (16), dengue
virus (6), and SINV (4, 15). It has been proposed that at least
in some cases, HS does not directly serve as a receptor. In-
stead, virus is concentrated on the two-dimensional cell surface
upon attachment to HS, which enhances the probability of
virus-receptor interaction. For some viruses, the affinity for HS
appears to be a consequence of passage in cell culture. It was
shown that newly isolated, unpassaged strains of SINV do not
bind to heparin and attach poorly to cells in culture relative to
laboratory-adapted strains of the virus (4, 15). After as few as
three passages in cell culture, these strains can acquire changes
that allow them to attach to HS. We show here that the RRV
T48 strain does not bind to heparin but can be adapted to bind
by passage in CEF or by site-directed mutagenesis of specific
amino acid residues in the E2 glycoprotein.
The N218R and N218K mutants replicated to 32- and 320-
fold-higher titers, respectively, than wild-type RRV in CEF but
did not approach the levels of SINV replication. The binding of
N218R and N218K to immobilized heparin, however, was sim-
ilar to that of SINV. This suggests that the N218R and N218K
viruses have an affinity for cell surface HS similar to that of
SINV, but this similar affinity does not lead to an equivalent
level of entry for the viruses, since fewer than half the cells are
infected by the RRV mutants. Since primary and secondary
CEF are heterogeneous in their expression of certain genes, it
is possible that only some of the cells express HS. However,
repeated passage of the CEF up to 10 times did not alter the
infection pattern of RRV or the mutants (data not shown).
Thus, by itself, binding to HS is probably insufficient to account
for virus entry into cells, and the functional receptor is likely to
be a discrete molecular entity.
Based on the results with SINV, the amino acid changes that
allow the virus to adapt to HS can arise in different regions of
the primary amino acid sequence of the E2 glycoprotein. It is
likely that multiple sites in the RRV E2 sequence also confer
HS binding to the virus. Passaging of NB5092 through CEF
resulted in two genetically distinct viruses (13). One virus had
a single amino acid change in E2 at residue 4 (E4R) and the
other had a change at residue 218 (N218K). Both of these
substitutions were located at or near residues that are changed
in mutants that were selected to escape neutralization by cer-
tain monoclonal antibodies, suggesting that they were exposed
on the surface of the virus. Most of the mutants with changes
at residue 218, including N218R and N218K, are no longer
neutralized by monoclonal antibody T10C9 (data not shown),
indicating that residue 218 is a determinant of reactivity with
T10C9. Residue 4 is part of an epitope for monoclonal anti-
body NB3C4, as a mutant in E2 (E4K) is poorly neutralized by
the antibody (13, 30). This epitope is most likely conforma-
tional, as escape mutants of NB3C4 map to residues 232 and
234. Since the N terminus of E2 is likely to be found at the top
of the glycoprotein spike based on cryoelectron microscopy of
a PE2-containing mutant virus, the substitution of a lysine
residue at position 4 in the CEF-adapted RRV presumably
converts it into an HS-interaction site. Interestingly, a RRV
mutant dE2 (a mutant with a deletion of residues 55 to 61 of
the E2 glycoprotein), is also less reactive with NB3C4 (11, 28),
and preliminary results suggest that this virus has acquired the
ability to bind HS (M. L. Heil, J. H. Strauss, and R. J. Kuhn,
unpublished data).
It has been shown that both lab strains of SINV and Vene-
zuelan equine encephalitis virus, which attach to HS, are less
virulent than wild-type isolates (2, 5). It has been suggested
that these mutants participate in a greater number of nonpro-
ductive cellular interactions, such as with the basement mem-
brane, and may be cleared more rapidly from the blood than
FIG. 5. Treatment of BHK cells with heparinase I. BHK cells were
treated with heparinase I at 37°C for 1 h. The treated cells were
overlaid with inoculum containing 100 to 200 PFU of virus (as assayed
on untreated BHK cells), and virus was allowed to adsorb for 1 h at
4°C. An agarose overlay containing MEM supplemented with 2% FBS
was added, and plaques were counted at 50 h postinfection. Data are
presented as a percentage of control virus without heparinase I treat-
ment of cells. This experiment was carried out twice.
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the parental virus. A similar effect on pathogenesis may also be
true in the case of HS-binding RRV strains. Infection of mice
with the N218R mutant resulted in the doubling of the 50%
lethal dose compared with the wild-type T48 strain of virus (R.
Weir, R. J. Kuhn, and J. H. Strauss, data not shown). These
results are consistent with previous suggestions that changes
that adapt an alphavirus to HS decrease its virulence in vivo (2,
5, 15).
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